iPSC-derived Cardiac Progenitor Cells

Cat.No.

CSC-00896L

Description

Cardiac progenitor cells (CPCs) are also ideal for identifying and helping to avoid drug-mediated cardiac developmental toxicity problems across multiple programs, an application for which scientists require consistent and dependable access to human CPCs. Creative Bioarray's iPSC-derived Cardiac Progenitor Cells provide a robust, reproducible, and relevant source of cells to advance drug development and cardiac regenerative medicine programs.

Species

Human

Source

Differentiated from a reprogrammed human
iPS cell line

Recommended Medium

iPSC-derived Cardiac Progenitor Cell Medium

Applications

Drug development, Cardiac regenerative medicine

Size

At least 5 million cells per vial

Storage

Liquid nitrogen

Shipping

Dry Ice

Quality Control

Sterility, Safety, HIV/viruses, bacteria, fungi: negative.

Storage and Shipping

Remove cryovials (dry ice packaging) and place the vial into liquid nitrogen for storage. Alternatively, thaw and use the cells immediately.

Citation Guidance

If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Ask a Question

Write your own review